Post by PharmaShots

LEO Pharma secures the US FDA acceptance of sNDA for Anzupgo to expand into pediatric Chronic Hand Eczema, aiming to address a significant unmet need in adolescents with limited treatment options Subscribe to our weekly newsletter and never miss a beat: https://lnkd.in/gTU62Zbz #leopharma #anzupgo #delgocitinib #phaseiii #deltateen #regulatory #chronichandeczema #usfda #snda https://lnkd.in/gK4Yxpdx